: The effect of freezing on fetal DNA fragmentation in maternal plas-
For clinical purposes, it is very important to be able to evaluate the stability of maternal plasma DNA. The first part of the present study (Study 1) assessed the effect of freezing on fragmentation of fetal DNA in maternal plasma. Fetal DNA is reportedly cleared from maternal blood with a half-life of 16.3 min 18). Since fetal DNA might be excreted in urine, such a source could be used for noninvasive prenatal DNA diagnosis. Therefore, the second part of the present study (Study 2) assessed differences in DNA fragmentation between plasma and urine from pregnant women. The subject group was comprised of seven pregnant women bearing a male fetus at 25-40 weeks gestation (median, 33 weeks). Samples of peripheral blood and urine were collected from all pregnant women. After extracting fetal DNA from both plasma and urine samples, three different-sized SRY gene amplicons (63, 107 and 137 bp) were amplified, and the fragmentation of fetal DNA in plasma and urine from pregnant women was evaluated . Fragmentation was then compared between urine DNA and plasma DNA. Strict precautions were taken against contamination and multiple negative controls (water) were included in every analysis. All patients in the study were enrolled at the Department of Obstetrics and Gynecology, Showa University Hospital, Tokyo, Japan. All subjects provided written informed consent to the use of biological specimens for research purposes. Study protocols were approved by the Ethics Committee of the Showa University School of Medicine. Solid line, Group A ; dotted line, Group B ; diamond, genomic DNA.
Results

Study 1
Analysis of male genomic DNA revealed that the efficiency of PCR was almost identical among the seven primer sets (Fig. 1) . In the analysis of maternal plasma, fetal DNA was detected in all plasma samples. When fetal DNA concentrations were determined using PCR amplification of the 63-hp amplicon, median concentrations in Groups A and B were 166 copies / ml (range, 59-930 copies / ml) and 175 copies l ml (range, 57-896 copies / ml), respectively (not significant, Mann-Whitney U-test). Relative concentrations of fetal DNA compared to the 63-hp amplicon in Group A samples were 53.1% (median; range, 23.3-140%). 42.0% (range, 22.0-71.4%), 9.2% (range, 2.3-57.8%), 2.0% (range, 0-11.8%) and 0.0% for PCR amplicons of 107 bp, 137 bp, 193 bp, 313 by and 524 bp, respectively. In Group B, relative concentrations were 70.4% (range, 31.4-122%), 40.9% (range, 22.7-112%), 11.9% (range, 0-20.7%), 2.3% (range, 0-7.9%) and 1.9% (range, 0-2.5%), respectively (Fig. 1) . Almost 60% of circulating fetal DNA was fragmented to <107 bp. Comparison between new and four-year-old samples revealed no significant difference in each amplicon size (Mann-Whitney U-test). Study 2 Fetal DNA in maternal plasma was detectable for all amplicon sizes, and relative concentrations for 107 and 137 by amplicons compared to 63 by were 71.9% (range, 22.7-107%) and 33.3% (range, 4.3-127%), respectively. Although fetal DNA in urine was not detected for the 107 and 137 by amplicons of the SRY sequence (Fig. 2) , fetal DNA in urine was detectable using a 63-hp amplicon in five of seven cases, although concentrations were extremely low (mean : 18.3 copies / 1). . However, plasma DNA concentrations are thought to gradually decrease under long-term cryopreservation, and therefore plasma DNA would be expected to become increasingly fragmented in storage. To confirm this hypothesis, the long-term effect of cryopreservation on fragment size of fetal DNA in maternal plasma was assessed. The present study found no differences in the fragmentation of plasma fetal DNA between time intervals of less than one month and < 4 years. This result indicates that plasma DNA is stable at -20°C for more than 4
years. The majority of fetal DNA in plasma from pregnant women appears to come from apoptosis of villous trophoblasts 21) . During apoptosis, DNA is thought to fragment to the size of nucleosomal DNA. Fragmented DNA is thus released into maternal blood and may further fragment in the maternal circulation 22). The present study shows that detection of longer fetal DNA fragments in maternal plasma is more difficult since approximately 60% of fetal DNA is fragmented to <107 bp. Again, the results indicate that a smaller target size is better for amplifying fetal sequences in maternal plasma. Lastly, the study reveals that cryopreservation does not affect fragmentation of plasma DNA. 
